Gallic acid-phospholipid complex: Drug incorporation and physicochemical characterization

Letters in Drug Design and Discovery

Volumn 8, Issue 3, 2011, Pages 284-291

  Singh, Devendra ^a   Rawat, Mohan Singh Maniyari ^a   Semalty, Ajay ^a   Semalty, Mona ^a  

^a H N B GARHWAL UNIVERSITY   (India)

Author keywords

Controlled release; DSC; Encapsulation; Gallic acid; Phosphatidylcholine; X RPD

Indexed keywords

GALLIC ACID; PHOSPHOLIPID;

ARTICLE; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; X RAY POWDER DIFFRACTION;

EID: 79952302734     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018011794578240     Document Type: Article

References (33)

1. Son, S.; Lewis, B.A. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure activity relationship. J. Agric. Food Chem., 2002, 50, 468-472.
2. Artico, M.; Di Santo, R.; Costi, R.; Novellino, E.; Greco, G.; Massa, S.; Tramontano, E.; Marongiu, M.E.; De Montis, A.; La Colla, P. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling. J. Med. Chem., 1998, 41, 3948-3960.
3. Montpied, P.; de Bock, F.; Rondouin, G.; Niel, G.; Briant, L.; Courseau, A.S.; Lerner-Natoli, M.; Bockaert, J. Caffeic acid phenethyl ester (CAPE) prevents inflammatory stress in organotypic hippocampal slice cultures. Mol. Brain Res., 2003, 115, 111-120.
4. Inoue, M.; Suzuki, R.; Sakaguchi, N.; Li, Z.; Takeda, T.; Ogihara, Y.; Jiang, B.; Cheny. Selective induction of cell death in cancer cells by gallic acid. Biol. Pharm. Bull., 1995, 18(11), 1526-1530.
5. Nakayama, T.; Hiramitsu, M.; Osawa, T.; Kawakishi, S. The protective role of gallic acid esters in bacterial cytotoxicity and SOS responses induced by hydrogen peroxide. Mutat. Res., 1993, 303(1), 29-34.
6. Serrano, A.; Palacios, C.; Roy, G.; Cespon, C.; Villar, M.L.; Nocito, M.; Gonzales-Porque, P. Derivatives of gallic acid induce apoptosis in tumoural cell lines and inhibit lymphocyte proliferation. Arch. Biochem. Biophys., 1998, 350, 49-54.
7. Ohno, Y.; Fukuda, K.; Takemura, G.; Toyota, M.; Watanabe, M.; Yasuda, N.; Xinbin, O.; Maruyama, R.; Akao, S.; Gotou, K.; Fujivara, T.; Fujivara, H. Induction of apoptosis by gallic acid in lung cancer cells. Anti-cancer Drugs., 1999, 10, 845-851.
8. Yoshioka, K.; Kataoka, T.; Hayashi, T.; Hasegawa, M.; Ishi, Y.; Hibasami, H. Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncol. Rep., 2000, 6, 1221-1223.
9. Salucci, M.; Stivala, L.A.; Maiani, G.; Bugianesi, R.; Vannini, V. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (CaCo2). Br. J. Cancer., 2002, 86, 1645-1651. (Pubitemid 34628121)
10. Kratz, J.M.; Andrighetti-Frohner, C.R.; Kolling, D.J.; Leal, P.C.; Cirne-Santos, C.C.; Yunes, R.A.; Nunes, R.J.; Trybala, E.; Bergstrom, T.; Frugulhetti, I.C.; Barardi, C.R.; Simoes, C.M. Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyle gallate. Mem. Inst. Oswaldocruz., 2008, 103(5), 437-442.
11. Kratz, J.M.; Andrighetti-Frohner, C.R.; Leal, P.C.; Nunes, R.J.; Yunes, R.A.; Trybala, E.; Bergstrom, T.; Barardi, C.R.; Simoes, C.M. Evaluation of anti-HSV-2 activity of gallic acid and pentyle gallate. Biol. Pharm. Bull., 2008, 31(5), 903-907.
12. Shahrzad, S.; Aoyagi, K.; Winter, A.; Koyama, A.; Bitsch, I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J. Nutr., 2001, 131, 1207-1210. (Pubitemid 32275101)
13. Ferruzzi, M.G.; Lobo, J.K.; Janle, E.M.; Cooper, B.; Simon, J.E.; Wu, Q.L.; Welch, C.; Ho, L.; Weaver, C.; Pasinetti, G.M. Bioavailability of Gallic Acid and Catechins from Grape Seed Polyphenol Extract is improved by Repeated Dosing in Rats: Implications for Treatment in Alzheimer's disease. J. Alzheimer's Dis., 2009, 18(1), 113-124.
14. Nijlen, T.V.; Brennan, K.; Mooter, V.; Blaton, N.; Kinget, R.; Augustijns, P. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions. Int. J. Pharm., 2003, 254, 173-181.
15. Nokhodchi, A. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharm. Sci., 2005, 8, 18-25.
16. Imai, T.; Shiraishi, S.; Saito, H.; Otagiri, M. Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans. Int. J. Pharm., 1991, 67, 11-20.
17. Zhang, M.; Li, X.H.; Gong, Y.D.; Zhao, N.M.; Zhang, X.F. Properties and biocompatibility of chitosan films modified by blending with PEG. Biomaterials, 2002, 23, 2641-2648.
18. Cai, K.; Rechtenbachb, A.; Haoa, J.; Bosserta, J.; Jandt, K.D. Polysaccharide protein surface modification of titanium via a layer-by-layer technique: characterization and cell behavior aspects. Biomaterials, 2005, 26, 5960-5971. (Pubitemid 40812362)
19. Panos, I.; Acosta, N.; Heras, A. New drug delivery system based on chitosan. Curr. Drug Discov. Technol., 2008, 5, 333-347.
20. Semalty, A.; Semalty, M.; Rawat, B.S, Singh, D.; Rawat, M.S.M. Pharmacosomes: the lipid based novel drug delivery system. Expert Opin. Drug. Deliv., 2009, 6(6), 599-612.
21. Parris, M.; Kidd.; Ph, D. Phosphatidylcholine: a superior protectant against liver damage. Altern. Med. Rev., 1996, 1(4), 258-274.
22. Semalty, A.; Semalty, M.; Rawat, M.S.M.; Federico, F. Supramolecular phospholipids-polyphenolic interactions: the PHYTOSOME® strategy to improve the bioavailability of phytochemicals. Fitoterapia, 2010, 81, 306-314.
23. Semalty, A.; Semalty, M.; Singh, D.; Rawat, M.S.M. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J. Incl. Phenom. Macrocycl. Chem., 2010, 67(3), 253-260.
24. Semalty, A.; Semalty, M.; Singh, D.; Rawat, M.S.M. Development and physicochemical evaluation of pharmacosomes of diclofenac. Acta Pharm., 2009d, 59, 335-344.
25. Li, Y.; Yang, D.J.; Chen, S.L.; Chen, S.B.; Sun-Chi Chan, A. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm. Res., 2007, 25, 563-77.
26. Yanyu, X.; Yunmei, S.; Zhipeng, C.; Qineng, P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm., 2006, 307, 77-82.
27. Kapoor A, Mujumdar DK, Yadav MR. Crystal forms of nimesulide-a sulfonanilide (non-steroidal anti-inflammatory drug). Indian J. Chem B., 1998, 37, 572-574.
28. Paradkar, A.R.; Pawar, A.P.; Chordiya, J.K.; Patil, V.B.; Ketkar, A.R.; Spherical crystallization of celecoxib. Drug. Dev. Ind. Pharm., 2002, 28, 1213-1220.
29. Babu, G.V.M.M.; Prasad, C.D.S.; Murthy, K.V.R. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water soluble drug nimodipine. Int. J. Pharm., 2002, 234, 1-17.
30. Moneghini, M.; Kikie, I.; Voinovich, D.; Perissutti, B.; Filipovic-Grcic, J. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterization and in vitro dissolution. Int. J. Pharm., 2001, 222, 129-138. (Pubitemid 32525794)
31. Maiti, K.; Mukherjee, K.; Gantait, A.; Saha, B.P.; Mukherjee, P.K. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007, 330(1-2), 155-163.
32. st century solutions for an ancient conundrum. Curr. Drug. Discov. Technol., 2009, 6(3), 192-199.
33. Perrut, M.; Jung, J.; Leboeuf, F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. micronization of neat particles. Int. J. Pharm., 2005, 288, 3-10.